Transgene Biotek Limited (BOM:526139)
3.200
+0.050 (1.59%)
At close: May 13, 2026
-8.31% (1Y)
| Market Cap | 242.46M -18.2% |
| Revenue (ttm) | 2.33M +1.7% |
| Net Income | -19.09M |
| EPS | -0.25 |
| Shares Out | 75.77M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 28,306 |
| Average Volume | 52,394 |
| Open | 3.150 |
| Previous Close | 3.150 |
| Day's Range | 3.100 - 3.250 |
| 52-Week Range | 1.830 - 5.260 |
| Beta | 0.96 |
| RSI | 63.40 |
| Earnings Date | May 26, 2026 |